Track Elevation Oncology Inc. Common stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Elevation Oncology Inc. Common stock ELEV · Stock Open Elevation Oncology Inc. Common stock in new tab

0.3650 USD
Add to portfolio
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Elevation Oncology Inc. Common stock (ELEV)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Elevation Oncology Inc. Common stock Logo Elevation Oncology Inc. Common stock Analysis (ELEV)

United States Health Care Official Website Stock

Is Elevation Oncology Inc. Common stock a good investment? Elevation Oncology Inc. Common stock (ELEV) is currently trading at 0.3650 USD.

Investor FAQ

Does Elevation Oncology Inc. Common stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Elevation Oncology Inc. Common stock?

Elevation Oncology Inc. Common stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.

Exchange Ticker
NMS (United States) ELEV
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion